Alexandra M McCoy

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Cognitive Decline

Artificial Intelligence

Temporal Lobe Epilepsy

Top Venues

International journal of molecular sciences

The international journal of neuropsychopharmacology

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra M McCoy, Thomas D Prevot, Dishary Sharmin, James M Cook, Etienne L Sibille, Daniel J Lodge
GL-II-73, a Positive Allosteric Modulator of α5GABA A Receptors, Reverses Dopamine System Dysfunction Associated with Pilocarpine-Induced Temporal Lobe Epilepsy. International journal of molecular sciences 24 (14) (2023)
Stephanie M Perez, Angela M Boley, Alexandra M McCoy, Daniel J Lodge
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease. International journal of molecular sciences 24 (8) (2023)
Alexandra M McCoy, Thomas D Prevot, Md Yeunus Mian, Dishary Sharmin, Adeeba N Ahmad, James M Cook, Etienne L Sibille, Daniel J Lodge
Extrasynaptic localization is essential for α5GABA A receptor modulation of dopamine system function. bioRxiv : the preprint server for biology (2023)
Stephanie M Perez, Angela M Boley, Alexandra M McCoy, Daniel J Lodge
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease. International journal of molecular sciences 24 (8) (2023)
Stephanie M Perez, Angela M Boley, Alexandra M McCoy, Daniel J Lodge
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease. International journal of molecular sciences 24 (8) (2023)
Alexandra M McCoy, Thomas D Prevot, Md Yenus Mian, James M Cook, Alan Frazer, Etienne L Sibille, Flavia R Carreno, Daniel J Lodge
Positive Allosteric Modulation of α5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle. The international journal of neuropsychopharmacology 25 (8) (2022)